US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist

33.640
+0.270+0.81%

Close Feb 28 16:00 ET

33.640
0.0000.00%

Post 20:01 ET

14.58BMarket Cap17.61P/E (TTM)

Royalty Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Royalty Pharma Q4 2024 Earnings Date

Currency：USDFeb 11, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	743.60M	593.64M	-149.96M
Miss Est.	+24.77%	-0.41%	-20.17%
EPS	0.25	0.35	+0.10
Beat Est.	-77.27%	-67.90%	+41.24%

Analyst Rating

Strong Buy

Feb 28, 2025

Royalty Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 657.801M	--
--	2025/Q1	-- / 724.685M	--
Feb 11, 2025	2024/Q4	594.000M / 743.604M	--
Nov 6, 2024	2024/Q3	565.000M / 731.832M	--
Aug 8, 2024	2024/Q2	537.000M / 645.290M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 657.801M--

--2025/Q1-- / 724.685M--

Feb 11, 20252024/Q4594.000M / 743.604M--

Nov 6, 20242024/Q3565.000M / 731.832M--

Aug 8, 20242024/Q2537.000M / 645.290M--

Unlock Free Earnings Estimates

Open Account

Royalty Pharma Earnings Reports

Royalty Pharma | 10-K: FY2024 Annual Report

Feb 12 13:22 ET

Royalty Pharma | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 09:27 ET

Royalty Pharma | 8-K: ROYALTY PHARMA REPORTS THIRD QUARTER 2024 RESULTS

Nov 6, 2024 07:37 ET

Royalty Pharma | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 09:04 ET